108 related articles for article (PubMed ID: 7857336)
1. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.
Taramelli D; Malabarba MG; Basilico N; Sala G; Mattina R; Cocuzza C
Arzneimittelforschung; 1994 Dec; 44(12A):1425-30. PubMed ID: 7857336
[TBL] [Abstract][Full Text] [Related]
2. Experimental immunological screening tests on pidotimod.
Coppi G; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulating activity of pidotimod.
Migliorati G; Nicoletti I; Riccardi C
Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
[TBL] [Abstract][Full Text] [Related]
4. Gene expression for interleukin-2 and tumor necrosis factor-alpha in the spleen of old rats under physiological condition and during septic shock. Possible pharmacological modulation.
Annoni G; Arosio B; Santambrogio D; Cullurà D; Gagliano N; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1433-6. PubMed ID: 7531977
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of pidotimod against experimental bacterial infections in mice.
Coppi G; Falcone A; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334
[TBL] [Abstract][Full Text] [Related]
6. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
7. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
[TBL] [Abstract][Full Text] [Related]
8. In vivo antiviral effects of pidotimod.
Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
Benetti GP; Illeni MT; Passera A; Bombelli G; Lavecchia G; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1503-5. PubMed ID: 7857352
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and preliminary pharmacological evaluation of pidotimod, its enantiomer, diastereomers and carboxamido derivatives.
Magni A; Signorelli G; Bocchiola G
Arzneimittelforschung; 1994 Dec; 44(12A):1402-4. PubMed ID: 7857331
[TBL] [Abstract][Full Text] [Related]
13. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
Barchielli M; Coppi G
Acta Physiol Hung; 1990; 75 Suppl():25-6. PubMed ID: 2371881
[No Abstract] [Full Text] [Related]
14. Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
Benetti GP; Fugazza L; Stramba Badiale M; Montalto F; Bombelli G; La Vecchia G; Illeni MT; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1476-9. PubMed ID: 7857346
[TBL] [Abstract][Full Text] [Related]
15. Pidotimod activity against chronic bronchitis exacerbations.
Ciaccia A
Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
[TBL] [Abstract][Full Text] [Related]
17. Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death.
Migliorati G; D'Adamio L; Coppi G; Nicoletti I; Riccardi C
Immunopharmacol Immunotoxicol; 1992; 14(4):737-48. PubMed ID: 1294620
[TBL] [Abstract][Full Text] [Related]
18. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
[TBL] [Abstract][Full Text] [Related]
19. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
Passali D; Calearo C; Conticello S
Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
[TBL] [Abstract][Full Text] [Related]
20. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
